MAGRINI, STEFANO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 14.041
EU - Europa 6.679
AS - Asia 3.323
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 23
SA - Sud America 18
OC - Oceania 12
Totale 24.121
Nazione #
US - Stati Uniti d'America 14.006
UA - Ucraina 2.294
CN - Cina 2.275
DE - Germania 1.110
IT - Italia 815
HK - Hong Kong 799
IE - Irlanda 539
FI - Finlandia 525
PL - Polonia 488
FR - Francia 378
GB - Regno Unito 286
SE - Svezia 99
IN - India 81
VN - Vietnam 56
RU - Federazione Russa 46
TR - Turchia 37
BE - Belgio 28
CA - Canada 26
SG - Singapore 24
EU - Europa 23
NL - Olanda 21
JP - Giappone 14
GR - Grecia 13
AU - Australia 10
BR - Brasile 9
ID - Indonesia 6
IR - Iran 6
MA - Marocco 6
MU - Mauritius 6
CH - Svizzera 5
MX - Messico 5
AR - Argentina 4
IL - Israele 4
MK - Macedonia 4
UG - Uganda 4
AT - Austria 3
BD - Bangladesh 3
CZ - Repubblica Ceca 3
EG - Egitto 3
KR - Corea 3
RO - Romania 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
DK - Danimarca 2
HU - Ungheria 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TH - Thailandia 2
AM - Armenia 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ES - Italia 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
LV - Lettonia 1
NO - Norvegia 1
RS - Serbia 1
SI - Slovenia 1
SL - Sierra Leone 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 24.121
Città #
Jacksonville 1.777
Fairfield 1.744
Woodbridge 1.608
Houston 1.138
Ashburn 986
Ann Arbor 899
Princeton 806
Chandler 803
Hong Kong 794
Cambridge 772
Wilmington 696
Seattle 676
Nanjing 578
Dublin 536
Warsaw 486
New York 310
Beijing 305
Dearborn 268
Helsinki 218
Nanchang 217
Des Moines 178
Changsha 136
Shenyang 134
Brescia 126
Hebei 125
Milan 122
San Diego 120
Jinan 111
Tianjin 106
Jiaxing 88
Shanghai 78
Kunming 63
Verona 58
Dong Ket 56
Hangzhou 50
Washington 46
Rome 40
Lancaster 36
London 33
Ningbo 32
Lanzhou 31
San Francisco 29
Taizhou 29
Zhengzhou 29
Norwalk 28
Brussels 27
Augusta 24
Kocaeli 24
Los Angeles 23
Haikou 22
Orange 22
Pune 22
Changchun 21
Guangzhou 20
Toronto 17
Boardman 16
Nürnberg 16
Taiyuan 16
Ceto 15
Redwood City 14
Athens 13
Hefei 11
San Mateo 11
Tokyo 11
Dresden 10
Fuzhou 9
Chiswick 8
Gunzenhausen 8
Iseo 8
Kilburn 8
Amsterdam 6
Bologna 6
Hanover 6
Hounslow 6
Isorella 6
Monza 6
Mountain View 6
Ardabil 5
Cazzago San Martino 5
Leawood 5
Phoenix 5
Rozzano 5
Bergamo 4
Berlin 4
Chicago 4
Chongqing 4
Cremona 4
Cuernavaca 4
Delhi 4
Falkenstein 4
Falls Church 4
Florence 4
Frankfurt am Main 4
Lappeenranta 4
Melbourne 4
New Bedfont 4
Palermo 4
Parma 4
Singapore 4
Sydney 4
Totale 18.036
Nome #
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 205
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 200
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 174
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 163
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 160
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 155
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 152
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 151
Pros-IT CNR: an Italian prostate cancer monitoring project 146
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 142
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 142
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 140
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 137
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 137
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 135
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 134
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 132
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 129
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 128
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 128
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 124
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 123
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 123
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 121
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 119
Role of external beam radiotherapy in the treatment of relapsing meningioma 119
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 118
Carboplatin (JM8), etoposide (VP16) and thoracic Irradiation for small cell lung cancer (S.C.L.C.): An evaluation of lung toxicity 116
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 116
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 115
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 113
Non-palliative radiotherapy in ab initio oligometastatic prostate cancer: an Italian national survey 113
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 113
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 112
Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial. 111
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 111
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 111
Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series 110
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 109
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 109
Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma 108
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 108
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 107
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 107
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 107
Extreme hypofractionation for early prostate cancer: Biology meets technology 107
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 106
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 106
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 106
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 105
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 105
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 104
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 104
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 103
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 102
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 102
From Molecular to Clinical Radiation Biology of Glioblastoma 101
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 101
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 99
Radiotherapy in Small Cell Lung Cancer 98
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 98
Which role for radiation therapy in ethmoid cancer? A retrospective analysis of 84 cases from a single Institution 97
Association between testicular cancer and spina bifida occulta 96
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 96
Information Retrieval in Medicine: an Extensive Experimental Study 95
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 95
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 92
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 92
Nasopharyngeal carcinoma 91
Merkel Cell Carcinoma: Report of Two Cases and Clinical Considerations 91
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 91
Radioterapia ("extended field") versus chemioterapia (MOPP) nel trattamento del m.di Hodgkin (stadio patologico I-IIA): risultati a 10 anni di uno studio prospettico randomizzato italiano 90
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 90
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 89
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 89
Cetuximab and Radiation Therapy in Head and Neck Cancer 89
Radical radiotherapy of bladder cancer retrospective analysis of a series of 459 patients treated in an Italian Institution 88
Limited-stage small-cell lung cancer treated with early chemo-radiotherapy: the impact of effective chemotherapy. 88
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 88
GUROPA survey: genito-urinary radiation oncology prescription attitudes 88
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 88
The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hospital 87
Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study. 86
The updated ESTRO core curricula 2011 for clinicians, medical physicists and RTTs in radiotherapy/radiation oncology. 86
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 86
Long term nervous system damage from radiation of the spinal cord: an electrophysiological study 85
Chordoma- Natural history, treatment and prognosis. The Florence Radiotherapy Department experience and a critical review of the literature 85
Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution. 85
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 85
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 85
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 85
Comparison of the conventional "box" technique with two different "conformal" beam arrangements for prostate cancer treatment 84
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. 84
Results of radiotherapy of prostate cancer: the Florence experience 84
Radiotherapy in case of locally advanced prostate cancer: long-term follow-up in 223 patients 84
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 84
Duration of androgen suppression in the treatment of prostate cancer 83
Survival and toxicity of radical radiotherapy (with or without brachytherapy) for FIGO stage I and II cervical cancer: a mono-institutional analysis. 83
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 83
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 83
Totale 10.910
Categoria #
all - tutte 118.634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.634


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019828 0 0 0 0 0 0 0 0 0 0 450 378
2019/20206.593 1.064 162 179 688 276 816 589 770 383 1.011 185 470
2020/20214.868 82 527 171 578 187 635 130 584 781 470 523 200
2021/20222.644 143 488 47 104 44 137 113 211 155 305 229 668
2022/20232.483 449 133 72 160 173 638 8 236 305 143 83 83
2023/20242.375 131 48 253 129 119 529 91 116 826 67 66 0
Totale 24.627